WCN24-2419 ANGIOTENSIN II TYPE 2 RECEPTOR (AT2R) AGONIST C21 ELICITS A NEPHROPROTECTIVE EFFECT DURING RENAL ISCHEMIA/REPERFUSION BY STABILIZING THE PRIMARY CILIA IN TUBULAR CELLS by Tomás Rivabella Maknis, María Fernanda Fussi, Alejandro Pedro Pariani, Victoria Huhn, Cristian Favre, Sara María Molinas, Maria Cecilia Larocca

Get full text

WCN24-2292 RENOPROTECTIVE EFFECTS OF THE ANGIOTENSIN II TYPE 2 RECEPTOR (AT2R) AGONIST, C21, AGAINST ACUTE ISCHEMIC KIDNEY INJURY IN FEMALE RATS by MARIA FERNANDA FUSSI, Tomas Rivabella-Maknis, Maria Herminia Hazelhoff, Romina P. Bulacio, Susana B. Marquez, Romina Campagno, Jorge Luis Molinas, Anabel Brandoni, M Cecilia Larocca, Sara M. Molinas

Get full text

Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphoma by Cecilia Larocca, Ai-Tram N. Bui, John T. O’Malley, Anita Giobbie-Hurder, Marianne Tawa, Jessica E. Teague, Rachael A. Clark, Corey Cutler, Eric Jacobsen, David C. Fisher, Thomas S. Kupper, Nicole R. LeBoeuf

Get full text

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy by Laura C Cappelli, Bernice Kwong, Jarushka Naidoo, Jonathan Leventhal, Mario E Lacouture, Meghan J Mooradian, Douglas B Johnson, Justine Cohen, Aparna Hegde, Steven T Chen, Riley Fadden, Leyre Zubiri, Shawn Kwatra, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Yevgeniy R Semenov, Nicole R LeBoeuf, Krista M Rubin, Anna K Dewan, Alina Markova, Allireza Alloo, Daniel Q Bach, Amina Bougrine, Leeann Burton, Mariana Castells, Lauren Guggina, Victor Huang, Benjamin Kaffenberger, Daniela Kroshinsky, Cecilia Larocca, Jon McDunn, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Maxwell Sauder, Sheila Shaigany, Afreen Shariff

Get full text